Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
COYA is expected to report earnings to rise 400.00% to -64 cents per share on March 24
Q4'25
Est.
$-0.65
Q3'25
Beat
by $0.46
Q2'25
Missed
by $0.49
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.22
The last earnings report on November 12 showed earnings per share of -12 cents, beating the estimate of -58 cents. With 279.12K shares outstanding, the current market capitalization sits at 97.09M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. COYA showed earnings on November 12, 2025. You can read more about the earnings report here.